BioCentury | May 9, 2018
Distillery Therapeutics

Dermatology

...INDICATION: Dermatology Mouse and cell culture studies suggest RHBDF2 inhibition or sulforaphane could help treat palmoplantar...
...the footpad, knockout of RHBDF2 decreased footpad epidermis thickness compared with normal RHBDF2 expression. In RHBDF2-mutant...
...derived from patients with diffuse epidermolytic palmoplantar keratoderma (tylosis), the antioxidant sulforaphane decreased levels of RHBDF2...
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication: Various

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Various Inflammation; sepsis Rhomboid 5 homolog 2 (RHBDF2; iRhom2) Studies...
BioCentury | Feb 2, 2012
Distillery Therapeutics

Indication

...P. Lifton, Yale School of Medicine, New Haven, Conn. e-mail: richard.lifton@yale.edu Various Inflammation; sepsis Rhomboid 5 homolog 2 (RHBDF2...
Items per page:
1 - 3 of 3